Clinical trial

Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on…

NCT00373191 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed

Key facts

NCT number NCT00373191
Title Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Official title Effects of Surgery, Radiation Therapy, Chemotherapy, and Endocrine Therapy on High-Sensitivity C-Reactive Protein in Women With Operable Breast Cancer
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Breast Cancer
Intervention type Drug, Genetic, Other, Procedure, Radiation
Interventions chemotherapy, endocrine therapy, DNA methylation analysis, protein analysis, laboratory biomarker analysis, questionnaire administration, adjuvant therapy, conventional surgery, radiation therapy
Enrollment 35
Start date May 1, 2006
Primary completion Feb 1, 2009
Completion Dec 1, 2013
First posted Sep 7, 2006
Last update posted Oct 12, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies